Odomzo 200 mg hard capsules
Sponsors
European Organisation For Research And Treatment Of Cancer, Gruppo Oncologico Del Nord Ovest
Conditions
Nevoid Basal Cell Carcinoma SyndromeNewly Diagnosed Medulloblastomalocally advanced basal cell carcinoma
Phase 2
EORTC 1634-BTG (NOA-23): Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly Diagnosed Medulloblastoma (PersoMed-I)
CompletedCTIS2023-506193-12-00
Start: 2022-11-10End: 2025-09-10Target: 32Updated: 2025-03-28
A phase II, open-label study improving compliance and time of treatment after obtaining complete response through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (BCC) – the SONIBEC trial
Active, not recruitingCTIS2024-516797-29-00
Start: 2021-01-12Target: 21Updated: 2025-07-14
A phase II study of Sonidegib in Nevoid Basal Cell Carcinoma Syndrome (Gorlin) syndrome and sporadic BCC patients in EADO stage IIb. SIBLINGS TRIAL
RecruitingCTIS2024-515989-14-00
Start: 2025-04-17Target: 15Updated: 2025-12-18